Natural Capsules Profit & Loss Annual

BSE: 524654 | NSE: - | ISIN: INE936B01015 | Sector: Biotechnology & Drugs

287.00 -10.50 (-3.53%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	155.42	172.37	135.07	79.51
Total Revenue	155.42	172.37	135.07	79.51
Costof Revenue Total	78.67	100.81	59.80	37.43
Gross Profit	76.75	71.57	75.27	42.09
Selling/ General/ Admin Expenses Total	12.37	33.99	9.62	8.05
Depreciation/ Amortization	8.67	7.21	5.04	4.31
Other Operating Expenses Total	44.46	0.15	40.27	23.11
Total Operating Expense	144.17	144.54	114.73	70.72
Operating Income	11.25	27.83	20.34	8.80
Interest Inc( Exp) Net- Non- Op Total	-51.30	-27.88	-17.39	-3.17
Other Net	1.93	-0.10	0.79	0.68
Net Income Before Taxes	8.05	24.99	19.39	9.16
Provisionfor Income Taxes	2.50	6.55	5.47	2.24
Net Income After Taxes	5.55	18.45	13.91	6.91
Net Income Before Extra Items	5.55	18.45	13.91	6.91
Net Income	5.55	18.45	13.91	6.91
Income Availableto Com Excl Extra Ord	5.55	18.45	13.91	6.91
Income Availableto Com Incl Extra Ord	5.55	18.45	13.91	6.91
Diluted Net Income	5.55	18.45	13.91	6.91
Diluted Weighted Average Shares	0.89	0.93	0.62	0.76
Diluted EPS Excluding Extra Ord Items	6.23	19.89	22.32	9.09
DPS- Common Stock Primary Issue	0.00	1.00	1.00	0.82
Diluted Normalized EPS	6.23	19.85	22.32	6.93
Research Development	-	23.89	-	-
Unusual Expense( Income)	-	0.00	0.00	-2.18
Gain( Loss)on Saleof Assets	-	0.45	-	-